Traumatic brain injury (TBI) is the leading cause of death and disability in the first four decades of life. A central concern in TBI is how to identify tissue injury and remodeling, and how such information can inform clinical decision-making, treatment, and prognostication. Neurologic biomarkers, quantitative indicators of brain dysfunction or damage, may be obtained via sampling of behavioral phenotypes, biological tissues (blood, CSF, brain interstitial fluid), electrophysiological recordings, or neuroimaging. Biomarker research has concentrated on single marker assays, however an emerging body of work suggests that multi-marker panels may enhance sensitivity and specificity for acute neurologic injury; there is also considerable interest in genomic, proteomic and lipidomic profiles. At the Third Annual Johns Hopkins TBI Conference, seminal research into TBI biomarkers will be presented and discussed by an interdisciplinary panel of experts who are internationally recognized for their work in the field.
|Contact No. :|
Conference Fee Details
|Conference Fee||:||USD $275.00|
|Early Fee Last date||:||NA|